Home
Conditions
Mesonephroma

Clinical trial condition

Mesonephroma

Explore clinical trials studying Mesonephroma. Study availability and eligibility vary by location and protocol.

46 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Mesonephroma trial results

Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

NCT03067181

Conditions: Carcinoma, Embryonal, Childhood Extracranial Germ Cell Tumor, Endodermal Sinus Tumor, +34 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 629 locations

View Trial Details

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations: Hospital São Carlos Fortaleza, Ceará, Brazil

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital Santa Cruz Curitiba, Paraná, Brazil

IDOR Recife Recife, Pernambuco, Brazil

View Trial Details

Recruiting

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04715191

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

NCT07148050

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

NCT06198296

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Recruiting

Molecular Epidemiology of Pediatric Germ Cell Tumors

NCT05564026

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Embryonal, +20 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

NCT06418789

Conditions: Adenocarcinoma, Carcinoma, Choriocarcinoma, +16 more
Locations: National Medical Research Center of Oncology named after N.N.Petrov Ministry of health of Russia Saint Petersburg, Russian Federation, Russia

View Trial Details

Not Yet Recruiting

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

NCT07224568

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
Locations: Fred Hutch Cancer Center Seattle, Washington, United States

View Trial Details

Completed

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

NCT06341998

Conditions: Endodermal Sinus Tumor, Germ Cell Tumor, Mesonephroma, +4 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Completed

Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

NCT06470464

Conditions: Disease Attributes, Endodermal Sinus Tumor, Germ Cell Tumor, +8 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Mesonephroma

Mesonephroma trial results

Related conditions